Compounds for the treatment of metabolic disorders

Details for Australian Patent Application No. 2004212905 (hide)

Owner Wellstat Therapeutics Corporation

Inventors Lee, Albert; Sharma, Shalini; Hodge, Kirvin L.; Von Borstel, Reid W.

Agent FB Rice

Pub. Number AU-B-2004212905

PCT Pub. Number WO2004/073611

Priority 60/447,168 13.02.03 US

Filing date 9 February 2004

Wipo publication date 2 September 2004

Acceptance publication date 9 October 2008

International Classifications

A61K 31/00 (2006.01)

A01N 37/00 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids

A61K 31/075 (2006.01) - Ethers or acetals

A61K 31/085 (2006.01)

A61K 31/195 (2006.01)

A61K 31/216 (2006.01)

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

C07C 69/734 (2006.01) Esters of carboxylic acids

C07C 69/76 (2006.01) Esters of carboxylic acids

Event Publications

7 July 2005 PCT application entered the National Phase

  PCT publication WO2004/073611 Priority application(s): WO2004/073611

9 October 2008 Application Accepted

  Published as AU-B-2004212905

5 February 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004212914-Expandable intervertebral implant cage

2004212904-Conformable wound dressing